Mann-Whitney U tests based on regression cutoffs for glioma subtypes showed significant variation of median MGMT promoter methylation scores only for IDHmut oligodendroglioma (18.2% vs. 27.2%, p = 0.0003, Supplementary Figure S2D, S2G, S2J). The gene discussed is MGMT; the disease is central nervous system cancer.